Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic October 20, 2024
Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery November 14, 2023
Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic October 20, 2024
Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery November 14, 2023